Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1995
10/12/1995WO1995027066A2 Dna encoding ubiquitin conjugating enzymes
10/12/1995WO1995027063A2 Rfb retrovirus genome
10/12/1995WO1995027062A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995WO1995027061A1 Protein tyrosine kinase agonist antibodies
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995027054A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting
10/12/1995WO1995027053A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY
10/12/1995WO1995027052A1 Human interleukin variants generated by alternative splicing
10/12/1995WO1995027051A1 Modified gad, a method for manufacturing of modified gad and a method to supply modified gad and peptide
10/12/1995WO1995027050A1 A method of preparing recombinant streptokinase
10/12/1995WO1995027046A2 Enzymatic antimicrobial compositions containing haloperoxidases
10/12/1995WO1995027045A1 The isolation and production of catalytic antibodies using phage technology
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995026986A1 Monoclonal antibody to oncofetal protein for treating and detecting cancer
10/12/1995WO1995026985A1 Modified receptors that continuously signal
10/12/1995WO1995026984A1 Process for producing composition containing bovine insulin-like growth factor 1
10/12/1995WO1995026983A2 Treatment or diagnosis of abnormal signal transduction disorders
10/12/1995WO1995026981A2 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
10/12/1995WO1995026979A1 Cytotoxic t-cell lymphocyte ('ctl') activity regulation by class i mhc peptides
10/12/1995WO1995026978A1 Cyclic peptide and process for producing the same
10/12/1995WO1995026973A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995WO1995026958A1 Pyrimidinyl derivatives as interleukin inhibitors
10/12/1995WO1995026750A1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
10/12/1995WO1995026749A1 Cryoprecipitated native fibrinogen concentrates
10/12/1995WO1995026748A1 Use of mcp-1 for inducing ripening of the cervix
10/12/1995WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/12/1995WO1995026745A1 TRANSFORMING GROWTH FACTOR-β INHIBITS INDUCIBLE NITRIC OXYDE SYNTHASE GENE TRANSCRIPTION
10/12/1995WO1995026744A1 Tumor necrosis factor inhibitors
10/12/1995WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995WO1995026740A1 Improved methods for transplantation using modified cells and t cell inhibitory agents
10/12/1995WO1995026737A1 Use of biopolymers for digestive tract injuries treatment
10/12/1995WO1995026725A1 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
10/12/1995WO1995026718A1 Compositions and methods for delivery of genetic material
10/12/1995WO1995026679A1 Therapeutic homeopathic dilutions of growth factors and methods of their use
10/12/1995WO1995024928A3 Heparin-binding growth factors for gene therapy and anterior eye disorders
10/12/1995WO1995022991A3 Block copolymers
10/12/1995WO1995020602A3 ANALOGS OF THYMOSIN α¿1?
10/12/1995WO1995009232A3 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof
10/12/1995DE4412190A1 Prevention of snoring
10/12/1995DE4411718A1 RFB-Retrovirusgenom RFB retrovirus genome
10/12/1995CA2187200A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995CA2187193A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides
10/12/1995CA2186913A1 Compositions and methods for delivery of genetic material
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/12/1995CA2186857A1 Monoclonal antibody to oncofetal protein for treating and detecting cancer
10/12/1995CA2186854A1 Human interleukin variants generated by alternative splicing
10/12/1995CA2186783A1 Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions
10/12/1995CA2186636A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995CA2186635A1 .alpha.-1-antichymotrypsin analogues having chymase inhibiting activity
10/12/1995CA2186527A1 Improved methods for transplantation using modified cells and t cell inhibitory agents
10/12/1995CA2186392A1 Therapeutic homeopathic dilutions of growth factors and methods of theiruse
10/12/1995CA2186370A1 Use of mcp-1 for inducing ripening of the cervix
10/12/1995CA2186107A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting
10/12/1995CA2185228A1 Cryoprecipitated native fibrinogen concentrates
10/12/1995CA2185211A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995CA2184756A1 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/12/1995CA2182966A1 Enzymatic antimicrobial compositions
10/12/1995CA2182700A1 Screening method using the rzr receptor family
10/11/1995EP0676474A1 Cloning and expression of a hybrid transforming growth factor-beta-1/transforming growth factor-beta-2
10/11/1995EP0676472A1 Human manganese superoxide dismutase (hMn-SOD)
10/11/1995EP0676471A2 Effector proteins of rapamycin
10/11/1995EP0676470A1 Stem cell factor
10/11/1995EP0676469A2 Transcription Factor APRF
10/11/1995EP0676468A2 Human T-cellreceptors, their uses in diagnosis and therapy of diabetes mellitus
10/11/1995EP0676414A1 Lipases immobilized in sol-gel processed hydrophobic materials
10/11/1995EP0676413A2 Interferon-alpha/beta binding protein, its preparation and use
10/11/1995EP0676411A2 Peptides and pseudopeptides derived from tachykinine, their preparation and their pharmaceutical compositions
10/11/1995EP0676199A1 Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections
10/11/1995EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/11/1995EP0675957A1 Vaccines against varicella-zoster virus (vzv)
10/11/1995EP0675956A1 New protein from urine named component b
10/11/1995EP0675955A1 Molecular flashlight
10/11/1995EP0675904A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus
10/11/1995EP0675902A1 Endothelin antagonists
10/11/1995EP0675901A1 Difluoro-pentapeptide derivative anti-inflammatory agents
10/11/1995EP0675900A1 Antibiotics ge 37468 a, b and c
10/11/1995EP0675899A1 NOVEL INHIBITORS OF FACTOR Xa
10/11/1995EP0675736A1 Improved synthesis of polymer bio-active conjugates
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675734A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT
10/11/1995EP0675733A1 Peptide-carbohydrate conjugates generating t-cell immunity
10/11/1995EP0675732A1 Use of relaxin as therapeutic or preventing agent
10/11/1995EP0675731A1 Treatment of cytomegalovirus infection
10/11/1995EP0675730A1 Therapeutic combination containing interferon
10/11/1995EP0675729A1 ACTIVATION OF p53 PROTEIN
10/11/1995EP0675728A1 Products and methods for improving keratinocyte adhesion to the dermis
10/11/1995EP0675727A1 Glycolipid enzyme-polymer conjugates
10/11/1995EP0629129A4 Method for kidney tubulogenesis.
10/11/1995EP0506716B1 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
10/11/1995EP0460167B1 Humanised antibodies
10/11/1995EP0397700B1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen
10/11/1995CN1109908A Productive process and use of human anti-tumour alpha type interferon alpha 1/114 Ala, alpha 1/158 Val and mutant thereof
10/11/1995CN1109891A Methods for preventing degradation of protein C
10/11/1995CN1109781A Eye drops-type insulin liquor and producing process thereof
10/11/1995CN1109780A Sustained-release preparation of anti-endothelin substance
10/11/1995CN1029977C Human insulin analogues
10/10/1995US5457196 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
10/10/1995US5457191 3-deazapurines
10/10/1995US5457189 Antisense oligonucleotide inhibition of papillomavirus
1 ... 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 ... 3163